Source: Webindia123

Jubilant Life Sciences: Jubilant launches Remdesivir in India for treatment of COVID-19

Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment through its distribution network.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Syed Kazmi's photo - President & CEO of Jubilant Life Sciences

President & CEO

Syed Kazmi

CEO Approval Rating

62/100

Jubilant Life Sciences is an integrated pharmaceutical company that provides specialty medicines, nutritional products and drug discovery solutions. Read more